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FOREWORD
It is a special pleasure for me to contribute something, even something
so meager as the present communication, to the number of the Yale Journal
of Biology and Medicine issued in honor of John R. Paul. It is 30 years
since we first met and began, each in his own way, to study certain aspects
of poliomyelitis. Together we have passed through an exciting era in the
development of knowledge of this disease. The studies of John Paul and
his associates greatly contributed to our understanding of the nature of
poliomyelitis and to the ultimate goal of its elimination as a cause of
human misery. The subject of the present communication has also been of
interest to Dr. Paul, who drew attention to the increasing occurrence of
epidemics of poliomyelitis in South America in his article concerned with
endemicand epidemic trendsofpoliomyelitis in Central and South America.'
* * *
INTRODUCTION
Recent epidemiologic and laboratory studies have provided evidence
that in orally administered, live, attenuated poliovirus vaccine we now
have a tool with which the complete elimination of poliomyelitis can be
undertaken.7 The public health authorities of several countries in South
America have recently decided to initiate nation-wide programs of im-
munization with oral poliomyelitis vaccine, and I was invited to consult
with them about various aspects of such a program.
The basic information that one needs for deciding on the type of
program that is most suitable for a given country includes data on
i) incidence of the disease in recent years, with special reference to de-
termining whether or not there is a pattern suggesting a regular periodicity
for years of high and low incidence, ii) the age distribution of the reported
cases in recent years as an index to the extent of natural immunization
and to the age groups which should be included in the initial nation-wide
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program, and iii) the seasonal incidence of the reported cases as an index
to the months of the year that may be optimum for community-wide pro-
grams. The purpose of this communication is to report this type of informa-
tion for Brazil, Uruguay, Argentina and Chile and to indicate the kind of
vaccination program that seemed most advisable for each of these countries.
BRAZIL
At the Fourth International Poliomyelitis Conference held at Geneva in
1957, Prof. Jose Martinho da Rocha8 presented some data on poliomyelitis
TABLE 1. MONTHLY ADMISSIONS OF NEW CASES OF ACUTE POLIOMYELITIS
TO ONE HOSPITAL (JESUS) IN Rio DE JANEIRO, 1952-1961*
Month 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961
January 14 24 4 6 3 12 48 25 25 24
February 0 56 7 9 5 5 13 9 12 15
March 4 68 13 11 13 16 15 7 17 31
April 2 73 21 3 20 15 8 17 29 34
May 8 108 57 12 16 11 6 9 35 65
June 6 82 43 9 18 3 8 8 61
July 1 49 44 9 34 7 15 9 38
August 5 17 24 9 50 15 28 4 19
September 5 16 13 9 40 10 37 11 18
October 6 6 12 10 35 25 55 11 15
November 18 4 15 13 36 32 87 6 10
December 26 6 4 11 14 69 46 5 19
Total 95 509 257 111 284 220 366 121 289
* Data supplied by Dr. Oswaldo P. Campos.
in Brazil, and called attention to the absence of exact statistical information.
This absence of adequate statistics still obtains, but an idea of the relative
incidence of the disease in different years, months, and age groups can be
obtained from the hospitals to which patients are admitted during the acute
phase of poliomyelitis. The data obtained from only one such hospital
in Rio de Janeiro, which were made available to me by Dr. Oswaldo P.
Campos are shown in Table 1. In the southern hemisphere, one obtains a
better idea of the annual fluctuation in the number of cases by grouping
the data for the periods of 1 July to 30 June than for the periods of
1 January to 31 December, and this was done in Table 2 with the data
from the Jesus Hospital in Rio de Janeiro. It can be seen that while during
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the past nine years there were two peak periods in 1952-1953 and in 1958-
1959, the incidence of admissions during the intervening years is not
strikingly lower than the peak years. It is noteworthy, that in the incom-
plete statistics of the Federal Health Service, the city of Rio de Janeiro is
reported as having had 37 cases in 1952, 746 cases in 1953, and 357 cases
in 1954. In the city of Sao Paulo, according to the same statistics, the
number of cases reported annually from 1944 to 1952 ranged from 3 to 29,
with 136 in 1953, 42 in 1954, and 127 in 1955. During my visit to Sao
Paulo I was informed that about 1200 cases of paralytic poliomyelitis were
admitted to the hospitals of the city in 1960, and that in the years im-
TABLE 2. VARIATIONS IN ANNUAL INCIDENCE (JULY 1-JUNE 30) AND
IN MONTHS OF HIGHEST INCIDENCE OF POLIOMYELITIS IN
Rio DE JANEIRo-BASED ON ADMISSIONS TO JESUS HOSPITAL
Period of Total no. Months with 20 Peak month and
July 1-June 30 admitted or more cases no. of cases
1952-1953 472 XII, I, II, III, IV, V, VI V-108
1953-1954 243 VII, IV, V, VI V- 57
1954-1955 162 VII, VIII VII- 44
1955-1956 136 IV IV- 20
1956-1957 271 VII, VIII, IX, X, XI VIII- 50
1957-1958 256 X, XI, XII, I XII- 69
1958-1959 343 VIII, IX, X, XI, XII, I XI- 87
1959-1960 216 I, IV, V, VI VI- 61
1960-1961 288 VII, I, III, IV, V V- 65
(11 months)
mediately preceding 1960 the admissions ranged from 400 to 500. There
was no indication in the data presented to me how many of these patients
were from outside the city of Sao Paulo, but there was general agreement
that poliomyelitis had become a much more important problem during
the past five years.
Rio de Janiero at about 230 south latitude has a climate which is rather
similar to that of Miami, Florida at about 260 north latitude. The data
shown in Table 2 indicate that while the peak months of incidence may
occur more often during the hot months of November to May than dur-
ing the cooler months of June to October, there is no regularity in dif-
ferent years. Ayroza Galvao et al.' reporting on poliomyelitis in the in-
terior of the state of Sao Paulo, which occupies about the same latitude as
Rio de Janeiro, showed that for the period of 1942-1951, the hot months
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of November to May had more poliomyelitis than the cooler months of June
to October, but they also pointed to irregularities during outbreaks in 1952
and 1953.
At the Fourth International Poliomyelitis Conference, Dr. Oswaldo P.
Campos'0 reported that among 1171 new cases of poliomyelitis of known
age that came under his personal observation from June 1954 to May
1957 in Rio de Janeiro, 59% were under one year of age, 88% under
three years, and 94%o under five years of age. Somewhat similar data for
Rio de Janeiro in 1954 were reported by Martins da Silva and SyvertonU
(see Table 3). Dr. Campos also pointed out to me that because of this
high incidence of infection with polioviruses during the first year of life,
TABLE 3. AGE DISTRIBUTION OF REPORTED CASES OF PARALYTIC
POLIOMYELITIS IN BRAzIL
Per cent
No. of under under
Source of data Region Period cases 3yrs. 5 yrs.
Martins da Silva and Rio de Janeiro 1954 356 83.6 91.8
Syverton
Campos " " " June '54-May '57 1171 88.1 93.8
Galvao Sao Paulo-urban 1949-1953 533 83. 90.
Is VP -rural "
I 663 71. 88.
the milder cases of paralysis are not noticed until the child begins to walk
or differences in growth of the affected and normal extremities become
apparent. Accordingly, the relative proportion of children acquiring the
disease during the first year of life is probably much higher. Borges"2 in
a recent report quoted a personal communication from Doctors A. M. Santos
and W. V. Silva of the Orthopedic Department of the Hospital of the
Faculty of Medicine of the University of Sio Paulo, that about 56% of
their poliomyelitis patients were under one year of age and 90%o under
two years of age. Somewhat lower percentages are reported for the
urban and rural areas of the interior of the state of Sao Paulo by Ayroza
Galvao et al.'
Payne' has previously considered the agreement that may be expected
and has been observed between estimates of susceptibility of certain
populations based on age incidence of reported cases and on serological
surveys. He indicated that while in most reported instances direct compari-
sons were not possible, there was a suggestion that the incidence of sus-
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ceptibles at a given age based on demonstrable antibodies for each of the
three types was higher than that based on age distribution of reported
cases. Payne called attention to the possibility that infection with one
type can exert partial protection against the paralytic effects of another
type; this has been demonstrated both experimentally and epidemiologically,
and may account for the fact that the age below which 90% of all
paralytic cases have occurred, may on serologic survey still show 20 to
30% of susceptibles to type 1 poliovirus or to one of the other 2 types.
Table 4 presents data calculated from the results obtained by Martins
TABLE 4. INCIDENCE OF ANTIBODY FOR EACH OF 3 TYPES OF POLIOVIRUS
IN CHILDREN OVER 6 YEARS OF AGE IN DIFFERENT SOCIOECONOMIC
GROUPS IN Rio DE JANEIRO -JULY TO AUGUST, 1954*
Per cent positive for type
Average I + One or
Socioeconomic age II + more
group years No. tested I II III III types
A-low 8.6 29 96.6 96.6 82.8 79.4 100
B-average 11.8 58 77.6 77.6 70.7 53.4 96.6
C-high 18.3 24 66.7 75.0 41.7 29.1 95.8
A2/3 of children from city slums and '3 from semi-rural school; overcrowding,
no running water or sewage disposal.
B-Children from small houses or apartments with running water, sewage disposal
and no overcrowding.
C-Children from upper income brackets-both Brazilian and foreign.
*Tabulated from data in Martins da Silva and Syverton.'
da Silva and Syvertone in a serology survey performed on children of
different socio-economic groups in Rio de Janeiro in 1954, i.e. after
2 years of relatively high incidence of the disease. It is noteworthy, there-
fore, that among 58 children over 6 years of age (average age of 11.8
years) from the "average" socio-economic group, there were still about
22% without antibody for type 1 or type 2, and 29%o without antibody
for type 3. Yet about 84%o of the reported cases were under 3 years of age
and 92% under 5 years of age during the period immediately preceding the
serologic survey. Furthermore, Martins da Silva and Syvertone reported
that 60 to 70% of all the cases came from the higher than average socio-
economic groups, and Campos'0 also stressed the fact that paralytic polio-
myelitis was rare among the children living in the slums of Rio de Janeiro.
It would appear, therefore, that as in the data analyzed by Payne,' the
possession of antibody against at least one of the 3 types of poliovirus
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(observed in 97% of Rio children in group B of Table 4) constitutes
a better index to susceptibility of a given population to paralysis than the
incidence of antibody for type 1, the most common paralytogenic type.
Without having any statistics on the proportion of the population in
Rio de Janeiro and Sao Paulo that lives in slums, I gathered the im-
pression, while driving about these cities, that the majority of the popu-
lation lives in very fine apartments and small homes, and quite a large
portion of the population in luxurious apartments and homes - and
yet it would appear that even under these conditions, the natural dissemin-
ation of polioviruses is so extensive that at least 90% of all the reported
cases of paralytic poliomyelitis continues to occur in children under 5 years
of age. The amount of Salk vaccine used in Brazil since 1956 has been
comparatively small10 and it is doubtful that it has had a significant effect on
the age incidence of the disease. Since extensive dissemination of polio-
viruses under such conditions is undoubtedly also associated with extensive
dissemination of other enteric viruses, as shown in the study in Toluca,
Mexico, it seemed advisable to recommend a vaccination program for
Brazil that was based on what was learned in Toluca.! This involves the
administration of two doses of trivalent vaccine, with a minimum of 105.3
TCD50 (50%o tissue culture infective doses) or 105 PFU (plaque forming
units) of each of the 3 types per dose, to all children from 6 weeks to under
5 years of age, at an interval of about 6 to 8 weeks. Since, under the
subtropical and tropical climatic conditions obtaining in most of Brazil,
there is no season that is free of extensive dissemination of polioviruses
and other enteric viruses, the oral vaccine program can be started at
any time of the year. It is conceivable that in the southernmost states of
Santa Catarina and Rio Grande do Sul, where truly cold weather may
occur during the months of June to October, there may be an advantage
to performing the mass vaccination programs during these months. Every
attempt is to be made to reach at least 70 to 80%o, and if at all possible
more, of the children in the designated age group, and to complete the
vaccine feeding within about a week or less in a given town, village, or
subdivision of a large city. After the conclusion of the community-wide
program in a given area, arrangements are to be made for immunizing
of the new generations of children during the first 6 months of life
by giving the first dose of trivalent vaccine at 2 to 3 months of age
(regardless of the time of the year that a child may reach that age) and the
second dose of trivalent vaccine at 4 to 5 months of age. The adminis-
tration of the vaccine in trivalent, instead of monovalent form, to these
children is based chiefly on administrative considerations. Private physic-
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ians, seeing children regularly during their first year of life, may be urged
to give the individual types separately at 6-week intervals (in the order
of I-III-II) with a booster dose of trivalent vaccine at 10 to 12 months
of age. It may be advisable for private physicians to administer the
trivalent vaccine to persons in the higher socio-economic groups up to 20
years or more, since about 71% of theolder children of this group were found
to be without antibody for one or another of the 3 types of poliovirus (see
Table 4).
TABLE 5. ANNUAL INCIDENCE OF PARALYTIC POLIOMYELITIS IN URUGUAY
BASED ON CASES REPORTED FROM JULY 1-JUNE 30
Period of July 1-June 30 No. of cases
1950-1951* 131
1951-1952 18**
1952-1953 57**
1953-1954 42**
1954-1955* 550
1955-1956 92
1956-1957 65
1957-1958 44
1958-1959 174
1959-1960 13
1960-1961 36
*Based on data reported by Leunda, et al.>
**These data are for period of June 1-May 31, from document by Dr. Oswaldo
Luzardo of the Ministry of Public Health.
Remaining data are based on document of Ministry of Public Health giving monthly
incidence of reported cases of paralytic poliomyelitis.
URUGUAY
At the Third International Conference on Poliomyelitis it was re-
ported that only about 15 to 20 cases had occurred in Uruguay during the
last few years.' Actually at least 248 paralytic cases are on record
for the period of July 1, 1950 to June 30, 1954 in the official statistics
of the Ministry of Health, and during the very next 12 months, between
July 1, 1954 and June 30, 1955, a total of 550 paralytic cases was reported
for this country with a population of about 2.6 million-a real epidemic with
an attack rate of about 21 per 100,000. A more accurate history of polio-
myelitis in Uruguay from 1906 to 1959, is contained in the report pre-
sented by Dr. Juan J. Leunda'5 for the National Committee against Polio-
myelitis of the Ministry of Public Health at the First International Con-
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ference on Live Poliovirus Vaccines (Washington, D.C., 1959).
In order to obtain an idea of a possible periodicity in years of high and
low incidence of the disease, the available data for 1950-1961 were ar-
ranged on the basis of incidence during the 12-month periods between
July 1 and June 30 (see Table 5). It may be seen that periods of
higher incidence recurred every 4 years since July 1, 1950. The unusually
low figure of 13 cases for the period of 1959-1960 is undoubtedly related
to the extensive use of live poliovirus vaccine (Lederle strains), principally
in Montevideo, during the nation-wide epidemic of 1958-1959. It is note-
worthy that of the 13 cases reported for the entire country between July
TABLE 6. AGE DISTRIBUTION OF PARALYTIC POLIOMYELITIS IN
URUGUAY, 1955-1960
Per cent in indicated group
Period Total no. 0-4 0-9 0-14 0-19 20 +
1955 551 60. 77. 87.3 92.4 7.5
1956 + 1957 124 60. 77. 85.5 90.3 9.7
1958 166 60. 72. 81.0 88.0 12.0
1959 + 1960 73 38. 54. 68.5 80.0 20.0
Prepared from data made available by Dr. Alberto Bertolini, Director de Division
Higiene, Ministerio de Salud Publica, Uruguay.
1, 1959 and June 30, 1960, only 1 was reported from Montevideo (popula-
tion of about 1 million). At the same time the data for 1960-1961 in-
dicated that the number of cases was again rising, and that in the absence
of a vaccination program another epidemic could be expected within 2
years.
The age distribution of the reported cases since 1955, shown in Table 6,
indicates a very much different picture than in Brazil. The age below
which about 90%o of the cases occurred in Uruguay was in the range of
20 years until 1958. In 1959 and 1960, only 80% of the cases were under
20 years, and 92%o under 30 years. The possibility was considered that the
extensive vaccination program in Montevideo in 1958-1959 may have pro-
tected relatively more persons under 20 years of age, but the data on
the age incidence of the cases in Montevideo and in the remainder of
Uruguay were not immediately available during my visit.
Uruguay is located between 30° and 350 south latitude and the
months of June to October are characterized by distinctly cold and cool
weather. The data on the monthly incidence of cases, shown in Table 7,
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indicate that particularly during the years of higher incidence, the peak
months were the hot months of December to April, except for 1958
which presented a somewhat different pattern.
Previous Use of Poliomyelitis Vaccine in Uruguay - According to the
official data of the Ministry of Public Health relatively little Salk
vaccine has been used. The number receiving 3 or more doses was as
follows: 1956 - 0; 1957 - 26,424; 1958 - 18,805; 1959 - 14,657;
1960 - 8,449.
TABLE 7. MONTHLY INCIDENCE OF PARALYTIC POLIOMYELITIS IN URUGUAY*
Period of Month Total no.
July 1-June 3C VII VIII IX X XI XII I II III IV V VI of cases
1950(1951** 1 1 4 4 6 22 44 26 11 5 3 4 131
1954-1955** 2 4 5 5 3 28 56 90 211 104 35 7 550
1956-1957 3 6 5 2 3 8 5 8 4 7 10 4 65
1957-1958 3 2 2 0 2 2 1 4 7 4 9 8 44
1958-1959 8 7 5 17 43 49 23 10 7 4 1 0 174
1959-1960 1 3 1 0 2 3 0 0 2 1 0 0 13
1960-1961 1 1 1 2 0 2 4 6 8 4 5 2 36
*Prepared froin document of Ministry of Public Health giving monthly incidence of reported
cases of paralytic poliomyelitis.
**Data in report by Leunda, et al.'
Some of the data on the mass vaccination program with live attenuated
poliovirus vaccine (Lederle) in Montevideo have already been reported,'
but there was considerable discussion among certain groups in Uruguay
about the effect of this program on the outbreak of 1958-1959 and on
the planning of a new, nation-wide program of vaccination with oral
vaccine. The vaccination program was at no time truly coordinated. From
May to September, 1958, when the incidence of cases was higher than
usual for these cold months of the year (see Table 7), only about
18,000 persons received the vaccine usually in the order of II-III-I
from private physicians on an individual basis. In October, 1958, when
a further increase in cases signalled the premature beginning of an epidemic,
which might have been expected on the basis of the periodicity shown in
Table 5, vaccination was begun on a much larger scale but still without
coordination, in the sense that it was spread over many months during
which period some were getting type 2, while others were getting type 3,
and still others type 1. The epidemic, later shown to be caused predominantly
by type 1 virus, terminated in the midst of the hot season, but this was also
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true of the 1950-1951 outbreak even though it began in December (see
Table 7). It is noteworthy that the 1958-1959 outbreak terminated during
the hot season also in the remainder of Uruguay where little or no vaccine
was employed. According to the published data' it would appear that only
about 50% or less of the young children in Montevideo received the vaccine,
which, taken together with its administration in an uncoordinated manner
over a period of many months, cannot be regarded as a proper way to
use oral vaccine in the face of an epidemic. There can be little doubt that
many cases of paralytic poliomyelitis were prevented by the vaccination.
According to Dr. Juan C. Bacigalupi of the University Institute of
Hygiene in Montevideo, there were no cases among the approximately
300,000 persons who received the type 1 oral vaccine. The following
considerations influenced the decision to include the persons who re-
ceived the oral vaccine in 1958-1959 in the nation-wide program that was
being planned for 1961:
a) most of the persons received the vaccine during the warm and hot
months of the year, during a type 1 outbreak, and in an uncoordinated
protracted manner - all of which may have contributed to inter-
ference with the optimum multiplication of the vaccine strains in an
unknown proportion of the people;
b) the type 2 Lederle strain is not highly immunogenic even in the
absence of interference;
c) refeeding these people will help increase the number of resistant
intestinal tracts in the community, and should thus greatly improve
the chances of breaking the chain of transmission of the naturally
occurring polioviruses;
d) revaccination would eliminate administrative complications.
Plan for Nation-wide Oral Vaccine Program in 1961. - The age in-
cidence and the seasonal incidence of poliomyelitis in Uruguay, suggested
that the conditions were comparable to those obtaining in North American
cities like Cincinnati,3 where the 3 types of oral vaccine were administered
separately to the pre-school and school children up to 18 years of age,
in the order of I-III-II. For Uruguay, the period of June to November
was optimum, and the age groups to be included in the first phase of the
program under the direction of the Ministry of Public Health would be
from 6 weeks to under 20 years. It was determined that the program should
be coordinated in such a way that the same type of vaccine would be ad-
ministered to all during a period of 7 to 10 days in any one region and
that this would be followed by a period of about 4 weeks when no vaccine
would be administered, before the next type is to be given in a similar
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manner. Phase two of the program, dealing with the immunization of the
oncoming generations of children, takes into consideration the extensive
availability of medical service to children during their first year of life
through private physicians and clinics. For example, Montevideo (popu-
lation about 1 million) alone has about 200 pediatricians, which is three
times as many as there are in Cincinnati and adjacent communities with a
comparable population. The procedure recommended here was to integrate
the administration of oral poliovirus vaccine into the existing schedule of
immunizations against diphtheria, pertussis, tetanus and smallpox, and
to administer each type separately in the order of I-III-II at the same
time as the other immunizations are given, without reference to the season
of the year. Since this would involve administration of one or another
type of the vaccine during the hot months of the year, when interference
from other intestinal viruses is more likely to occur in some instances,
it was also recommended that a trivalent dose of vaccine be given be-
tween 10 and 12 months of age, at a time when the child is brought for
abooster injection of diphtheria-pertussis-tetanus vaccines.
ARGENTINA
At the Third International Poliomyelitis Conference (Rome, 1954),
Dr. Bismarck Lucero'6 reported on the incidence of poliomyelitis in Argen-
tina up to 1953, and called attention to the fact that the majority of
cases occurred in children between 1 and 7 years of age. I am indebted to
Dr. Lucero and to Dr. Ignacio Pirosky, director of the Institute Nacional
de Microbiologia, Ministerio de Asistencia Social y Salud Publica, for
making available to me the data presented in Tables 8, 9 and 10. In 1956,
Argentina had its largest epidemic with a total of 6,496 paralytic cases
in a population of about 19.5 million, an attack rate of 33.3 per 100,000. If
a comparable epidemic had occurred in the U.S.A. with a population of
180 million, there would have been 60,000 paralytic cases. The highest
recorded incidence in the U.S.A. of 37.2 per 100,000 was in 1952 but
this also included so-called nonparalytic cases, and it is highly probable
that the attack rate for paralytic cases was closer to 20 per 100,000.
The monthly incidence data for the past 10 years were not immediately
available, and I therefore could not analyze the incidence of the disease
on a July 1-June 30 basis which is more illuminating in the search for
periodicity in the southern hemisphere. The January-December data
for 1949-1956, shown in Table 8, suggest a 2 to 3-year periodicity for
varying degrees of increase in incidence. I did not obtain precise data on
how much Salk vaccine has been used in Argentina in recent years nor on
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what proportion of the population had received 3 or more doses. However,
Salk vaccine is bought by the government from the lowest bidders, and
these bids are a matter of public record. Late in 1959 the government
obtained bids on 2 million doses (c.c.), in 1960 on 3.8 million doses, and
in April 1961 on 5 million doses.* In 1959 the total number of reported
paralytic cases was 1,050 and in 1960 it wa sagain about 1,000.
TABLE 8. PARALYTIC POLIOMYELITIS IN ARGENTINA, 1942-1959
Year
1942
1943
1944
1945
1946
1947
1948
1949
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
No. of cases
1338
1556
497
357
659
467
552
1103
586
1015
695
2579
871
435
6496
760
842
1050
Cases/100,000
9.1
10.6
3.3
2.5
4.2
2.9
3.6
6.5
3.4
5.7
3.8
14.0
4.6
2.3
33.3
3.8
4.2
5.1
Data fromn "Epidemiologia de la poliomielitis-formas paraliticas-ano 1958",
Ministerio de Asistencia Social y Salud Publica (Argentina), Seccion Estadisticas
Vitales, Buenos Aires, 1959.
Data for 1959 from official statistics of Health Ministry.
The age distribution of reported cases for 1954-1959, shown in Table 9,
indicates that the 90%o incidence has fluctuated from under 13 to under 10.
It is noteworthy, however, that in 1958 and 1959, about 81 to 83%o of
all cases were under 5 years of age.
Argentina includes territory lying between 220 and 550 south latitude,
with the majority of the population residing in the middle zone. Data for
* It is noteworthy that in 1960, the contracts went to two American companies first
at 10 American cents per dose and later at 7 cents per dose, and that in 1961 a
European company obtained the contract by offering vaccine at 5 cents a dose-prices
that are extraordinarily low by comparison with those obtaining in the U.S.A., Europe
and other South American countries.
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the monthly incidence of poliomyelitis were immediately available only
for 1958, and these show (Table 10) that December to May are generally
the months of highest incidence in the Buenos Aires area at 34.5° as
well as in Tucuman at 260 south latitude.
In considering various aspects of a nation-wide oral poliovirus vaccine
program for Argentina, there was no difficulty in deciding a) that the
optimum time would be the cool and cold months of the year, i.e. June
to November, and b) that children up to at least 9 and preferably 12
TABLE 9. AGE DISTRIBUTION OF REPORTED CASES OF PARALYTIC
POLIOMYELITIS IN ARGENTINA, 1954-1959
Per cent of total no. of known age in indicated year
Age group 1954 1955 1956 1957 1958 1959
Under 2 yrs. 41.8 41.4 43.6 32.7 56.4 53.6
" 5 " 71.0 74.4 74.6 72.7 80.7 83.1
" 10 " 86.0 90.0 87.2 86.6 90.2 91.8
" 13 " 90.5 94.3 90.5 89.9 93.9 93.7
" 15 " 93.8 95.3 92.2 91.7 94.8 94.2
" 20 " 95.3 97.3 94.8 94.0 96.6 96.2
" 25 " 97.4 98.6 96.8 96.5 97.9 97.1
Total no. of
known age 810 311 6496 760 842 1050
Prepared from data made available by Direccion de Enfermedades Transimissibles,
Ministerio de Asistencia Social y Salud Publica, Republica Argentina.
years should be included in the primary community-wide phase of vac-
cination. What was more difficult to decide was whether the children of
Argentina, with 80%o of the cases under 5 years of age, represented a
population with massive viral enteric infection throughout the year,
winter and summer, forwhom the Toluca model of two trivalent doses might
be optimum, or whether the dissemination of intestinal viruses may be
sufficiently suppressed during the winter season to expect that the separate
administration of the 3 types of vaccine would yield the best results.
It seemed to me that the distinctly high, summer incidence of poliomyelitis
indicated that there was much less dissemination of polioviruses, and
therefore also of enteric viruses generally, during the cold and cool months
of the year- and that the situation in Argentina was certainly not signifi-
cantly different from that obtaining in the low socio-economic groups in
Cincinnati or among the children of Czechoslovakia or Hungary. Accord-
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ingly, I recommended that the 3 types of oral vaccine be administered
separately in the order of I-III-II, with intervals of at least 6 weeks
between each type to allow for the maximum possible intrafamilial and
interfamilial spread of the viruses, as a means of reaching those children
who might have been in a refractory state because of infection with an-
other enteric virus at the time they received the vaccine. The maintenance
program in newborn children could follow the pattern recommended for
the U.S.A. and Uruguay where the facilities for medical care of children
TABLE 10. MONTHLY INCIDENCE OF PARALYTIC POLIOMYELITIS IN ARGENTINA IN 1958
Cases
Total per
Region cases 100,000 VII VIII IX X XI XII I II III IV V VI
Entire country 842 4.2 42 48 33 30 59 108 91 108 100 72 87 64
Buenos Aires 67 1.2 2 2 3 3 3 8 8 10 7 8 6 7
Districts adjacent
to Buenos Aires 216 10.0 13 I1 12 9 25 34 15 15 24 23 20 15
Tucuman 60 7.5 2 2 0 1 1 7 18 15 8 4 0 2
Data from document of Ministry of Health cited in Table 8.
during the first year of life permitted it, or could consist of the adminis-
tration of several doses of trivalent vaccine where -that would be ad-
ministratively more feasible.
CHILE
The epidemiology of poliomyelitis in Chile up until 1954 was described
by Horwitz, et al.,'7 and Borgono'8 reported some of the characteristics
of the epidemics in 1955-1956. I am indebted to Doctors J. M. Borgoino
and C. Ristori of the Department of Epidemiology of the Servicio Nacional
de Salud for the data presented in Tables 11, 12 and 13. Borgono'8 stressed
the fact that the official statistics on the incidence of poliomyelitis in Chile
are incomplete because private physicians only rarely reported cases that
are not admitted to the hospitals. An analysis of the incidence of polio-
myelitis in Chile, for the 12-month periods between July 1 and June 30
for 1947-1961 (Table 11), suggests a trend toward a 4-year periodicity
for years of higher incidence, excepting the period of 1953-1956 during
which two high years occurred. The great increase in poliomyelitis in
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recent years is most strikingly documented by the fact that during the
7 years from 1940-1946 only 343 cases were reported, with an avereage
case fatality rate of 14%, while during the 14 years between July 1, 1947
and June 30, 1961 a total of 6,070 cases were reported with an average
case fatality rate of 17.7%-oand this for a country whose total population
in 1955 was about 6.4 million and in 1960 about 7.6 million. The case
TABLE 11. REPORTED CASES OF PARALYTIC POLIOMYELITIS IN
CHILE BASED ON JULY 1 TO JUNE 30 GROUPING
Period of July 1-June 30 No. of cases
1947-1948 147
1948-1949 121
1949-1950 800
1950-1951 216
1951-1952 480
1952-1953 443
1953-1954 773
1954-1955 316
1955-1956 815*
1956-1957 336
1957-1958 356
1958-1959 367
1959-1960 529
1960-1961 371
Data supplied by Servicio Nacional de Salud.
* In an article published by Dr. J. M. Borgofio, of the Department of Epidemiology,
Servicio Nacional de Salud, in Revista del Servicio Nacional de Salud, 1: 207-221
(Dec.) 1956, the total number of cases for the period of October, 1955, to May, 1956,
is given as 864. Dr. Borgofio explained that his published data were obtained- by him
directly from the records of the different hospitals, and that official reports by the
hospitals to the National Health Service are not always complete.
fatality rates for 1958, 1959 and 1960 were 23.87O, 21.9%o and 18.5%o re-
spectively. These continuing high case fatality rates since 1940, suggest,
on the one hand, that this increase in poliomyelitis is not due to better
reporting, and, on the other, that perhaps only 50(%o of the total number
of paralytic cases are being reported-unless poliomyelitis in Chile is for
some reason more often fatal than in other countries. Dr. Hernan Romero,9
the official delegate of Chile to the Third International Conference on Polio-
myelitis (Rome, 1954) said: "The reporting of poliomyelitis in the general
population is defective." Although the government has been purchasing
Salk vaccine for sale to the population, I gathered the impression that a
413YALE JOURNAL OF BIOLOGY AND MEDICINE Vol. 34, Dec.-Feb. 196112
relatively small proportion of the children have received 3 doses, and the
incidence of poliomyelitis in the last few years does not show a significant
deviation from former years.
The age distribution of the reported cases in 1956-1960, shown in
Table 12, indicates that about 83%o of the reported cases occur under
5 years of age, and about 93%o under 10 years of age. There is also no
evidence of a recent shift in age distribution of the cases. Although Chile
TABLE 12. AGE DIsTRIBuTIoN OF REPORTED CASES OF PARALYTIC
POLIOMYELITS IN CHILE, 1956-1960
Per cent in indicated age group (years)
Year Total no. of cases Under 1 Under 5 Under 10
1956 719 24.3 86.5 94.9
1957 333 20.4 79.3 92.5
1958 328 21.3 83.8 93.0
1959 456 25.4 84.2 94.1
1960 546 23.1* 82.7* 92.1*
1959
Zona Norte 31 19.3 87.1 96.8
Zona Central 282 26.2 83.0 92.2
Zona Sur. 143 25.2 82.5 93.0
Prepared from data supplied by Servicio Nacional de Salud.
* Percentages calculated on basis of 532 cases of known age.
extends from a latitude of 180 to 550 south, 90% of the population
lives in the central and southern portions between 320 and 550 south
latitude. An analysis of the age distribution of cases in the 3 zones of
Chile in 1959 (Table 12) showed no significant differences. The monthly
incidence of cases in Chile in recent years, shown in Table 13, indicates
that the highest incidence is during the hot months of December to
April. It is noteworthy, however, that 13 of the 20 cases in 1960 in
Coquimbo province, which lies between 290 and 320, were reported during
the months of August to November.
The National Health Service had decided on a nation-wide oral polio-
virus vaccine program and two of the main questions concerned the age
groups to be included and whether to use two doses of trivalent vaccine
or the 3 types of vaccine separately. The immediately available data,
indicating that about 93%o of the reported cases occurred under 10 years
of age, suggested that including all children up to 9 years of age would
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certainly be adequate, and that it would be reasonable to give the vaccine
only to the age group in which 90%o of the reported cases occurred. With
regard to the dosage schedule, the same considerations arose here as were
discussed for Argentina, and the decision was against giving the two
trivalent doses. Administratively, however, two vaccine sessions were pre-
ferred to three, and it was, therefore, decided to give the Type 1 vaccine
first and then a combination of the Type 2 and 3 vaccines for the second
dose. This procedure yielded good results in the nation-wide program in
Czechoslovakia7 in 1960, and, according to Paul, Horstmann and their
associates (personal communication), also a very good antibody response
TABLE 13. MONTHLY INCIDENCE OF PARALYTIC POLIOMYELITIS IN CHILE
No. of cases in indicated month
Period of
July 1-June 30 VII VIII IX X XI XII I II III IV V VI
1955-1956 20 13 18 31 53 100 174 135 121 70 50 30
1956-1957 22 21 11 16 17 45 51 35 40 30 21 18
1959-1960 30 16 9 35 28 75 90 55 71 62 30 24
Data supplied by Dr. J. M. Borgofio, Department of Epidemiology, Servicio Nacional de
Salud.
among children in large families in New Haven, Conn., during the winter
of 1960. The main concern in such a program is that the intestinal re-
sistance and persistence of the antibody may not be as good as when
the type 2 and type 3 vaccines are given separately. Accordingly it was
decided that several hundred one and two year old children be tested for
antibody before and at various times after this vaccination schedule and
the results would help to determine whether still another dose of monovalent,
bivalent or trivalent vaccine should be given later on. It should be pointed
out that there was also an economic consideration since two doses of
trivalent vaccine would cost twice as much as the two doses consisting of
types 1 only and a mixture of types 2 and 3.
There was no question that the optimum time for community-wide
programs in Chile was during the cool and cold months of June to
November. It was also suggested that, if time permitted, the interval be-
tween administration of the Type 1 vaccine and the mixture of Types
2 and 3 should be at least 8 weeks, in order to provide the longest possible
time for intrafamilial and interfamilial spread of the virus.
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In discussing the type of program that would be most feasible for
immunization of the oncoming generations of children during the first
year of life, it became necessary to take into consideration the fact
that in Chile breast-feeding usually stops at 3 months, and that after
that time more than 50 per cent of the children obtain monthly rations of
dried milk. It appeared desirable to take advantage of this circumstance
and have the mothers bring the children for their poliovirus vaccine
when they come to get the milk. Under these circumstances, it would be
administratively impractical to keep track of which type of vaccine a given
child had had, and much simpler to administer two or more doses of
trivalent vaccine at monthly intervals, and a "booster" dose at about 10
to 12 months of age.
Questions of Interest Regarding Oral Poliovzrus Vaccine Programs
During the course of discussions on oral vaccination programs, the
following questions most often came under consideration:
Q. Why not give the vaccine to newborn children right after birth or
before 6 weeks of age?
A. Recent studies carried out by many investigators indicated that at
least 100 times the usual dose is needed shortly after birth to obtain
a response in at least 85% of children, and even with this large dose
the response may be still lower in breast-fed children. During com-
munity-wide programs there is no harm in giving the usual dose to
children under 6 weeks of age, provided provisions are made for re-
vaccination at a later age.
Q. Why must the vaccine be given initially in coordinated, community-
wide programs during a short period of time rather than on an in-
dividual basis over a long period as in the case of the Salk vaccine?
A. Oral vaccine, given on the same basis as Salk vaccine, can immunize
the individual but would be ineffective in rapidly eliminating the
naturally occurring polioviruses from the community, and poliomyelitis
would continue to occur in the remaining susceptible persons. Admin-
istration of the oral vaccine on a community-wide basis to at least
70%o or more of the most susceptible young children, in a coordinated
manner in the shortest possible time, has the following odjectives:
1) to make the largest number of intestinal tracts resistant to infection
in the shortest possible time as a means of quickly breaking the chain
of transmission of the naturally occurring polioviruses and thereby
protect also those in the family or community who are not immune;
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2) in temperate climates, where the different types of vaccine are given
separately, to avoid the interference which may occur when more than
one type of virus is spreading in the community; and 3) in subtropical
and tropical climates where there is massive enteric infection with other
viruses, the rapid administration of the trivalent vaccine to at least
80%o or more of the children under 5 years, is essential for temporarily
suppressing dissemination of the other enteric viruses and for allowing
nature to help disseminate the vaccine strains of polioviruses.
Q. Why should oral vaccine be given to persons who have already had
3 or more doses of Salk vaccine?
A. Becausce 1) it will immunize those who have failed to acquire immunity
or have lost it; 2) it will give a powerful boost to the immunity of those
who have not had a natural immunizing infection; and 3) it is neces-
sary to provide the resistance to infection in the intestinal tract which
is required for elimination of the naturally occurring polioviruses from
the community. This applies particularly to young children, who are
the most important spreaders of polioviruses.
Q. When the 3 types of oral vaccine are given separately, why are they
given in the order of I-III-II instead of I-II-III or some other
order?
A. Type I is given first because this quickly provides immunity against
the type of poliovirus that is responsible for at least 85%o of all paralytic
poliomyelitis and for most epidemics. Type III is given next not
only because it is next in importance as a cause of paralysis, but also
because it is easier to terminate a persisting Type III intestinal infection
by feeding Type II vaccine, which is the most dominant strain among the
3 types of vaccine, than vice versa. Moreover, when the Type II is
fed it helps to eliminate the persisting excretion of the Type I or Type
III viruses in those who are also susceptible to Type I.
Q. What is the simplest way of handling and administering the vaccine
in a community-wide program?
A. To avoid excessive shipping and storage costs it is best to obtain the
vaccine in undiluted bulk, then dilute it so that the dose (at least
1053 TCD5o) is contained in 2 drops (0.1 ml.), and store the diluted
vaccine in medicine dropper bottles at about -20°C. Under these con-
ditions, the potency of the diluted vaccine is known to be maintained
without loss for a period of at least 8 months. During the actual vac-
cination program the diluted vaccine can be kept in the clinic or
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doctor's office in an ordinary refrigerator at about +5°C for at least
7 days. For children of 2 years or older, who can chew a piece of sugar,
the simplest procedure is to put the 2 drops of diluted vaccine on a
lump of sugar. For younger children, the 2 drops of vaccine are
added to a teaspoonful of dilute simple syrup. Vaccine in the form of
candy, as prepared and used by Professor M. P. Chumakov and his
associates of Moscow, is very simple to use in older children, but it is
more expensive to prepare.
Q. Is a long period of public information and education necessary to obtain
the maximum public response for a community-wide program?
A. No. Experience with such programs in the U.S.A. and elsewhere
has shown that it is best to be prepared with vaccine and complete
plan of operations before beginning the intensive campaign of public
information. The best results are obtained when the public is told when
and where they will be able to get the vaccine in their own community or
neighborhood, and when they are faced with the necessity of making
a decision in a matter of days rather than weeks or months. One to
two weeks of public information have sufficed in most areas.
SUMMARY
Poliomyelitis has become of increasing importance in recent years in
Brazil, Uruguay, Argentina and Chile. The amount of Salk vaccine that
has been used in these countries has not significantly reduced the incidence.
In Brazil, 94%o of all reported cases occur in children under 5 years of age,
the disease occurs with only slight fluctuations in all months of the year,
and years with twice or more the annual incidence are uncommon. The
oral poliovirus vaccine program recommended for Brazil was, therefore,
based on the Toluca model, in which 2 doses of trivalent vaccine are to
be given with an interval of about 6 to 8 weeks to all children from 6 weeks
to under 5 years of age, without reference to season. For the new gener-
ations of children, subsequent to the initial community-wide program, two
doses of trivalent vaccine were recommended during the first 6 months
of life-the first at 2-3 months and the second at 4-5 months.
In Uruguay, Argentina, and Chile there is a distinctly higher incidence
of the disease during the hot months of December to April, and epidemic
years have occurred with varying periodicity. The age below which about
90%o of the reported cases occurred in recent years is in the range of 20
to 30 years in Uruguay, 10 to 13 years in Argentina, and probably 7
to 9 years in Chile. In these 3 countries, the optimum time for the initial
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community-wide programs is during the cool and cold months of June to
November. The age groups to be covered includes persons up to 20 years
in Uruguay, up to 12 years in Argentina, and up to 7 or 9 years in Chile.
In Uruguay and Argentina it seemed advisable to recommend the separate
administration of each of the 3 types of vaccine, while in Chile it was
decided, chiefly for administrative expediency, to give Type I first and a
mixture of 2 and 3 about 8 weeks later. The type of maintenance program
for the new generations of children was also different in Chile than in
Uruguay and Argentina. General questions of interest in relation to the
planning and organization of oral poliovirus vaccine programs are discussed.
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